Atrium Health Levine Cancer's Financial Toxicity Tumor Board mitigates financial distress among cancer patients, improving treatment outcomes and reducing insurance claim denials. A five-year study highlights its efficacy and suggests it as a best practice for cancer centers.

HaysMed CEO Edward Herrman joined a key HHS healthcare policy roundtable discussing rural healthcare challenges, Medicare Advantage concerns, regulatory burdens, and AI opportunities. Insights to inform federal support and reform.